研究成果
年分
作者
期刊
研究名稱
2022
Hu YF*, Lee AS, Chang SL, Lin SF, Weng CH, Lo HY, Chou PC, Tsai YN, Sung YL, Chen CC, Yang RB, Lin YC, Kuo TBJ, Wu CH, Liu JD, Chung TW, Chen SA.
Nat. Biomed. Eng. 2022; 6(4): 421-434. (IF: 29.234)
Biomaterial-induced conversion of quiescent cardiomyocytes into pacemaker cells in rats.
2022
Huang CC*, Chung CM, Yang CY, Leu HB, Huang PH, Lin LY, Wu TC, Lin SJ, Pan WH, Chen JW.
Front. Med. 2022; 9:863275. (IF: 5.058)
SLC12A3 Variation and Renal Function in Chinese Patients With Hypertension.
2022
Huang CC*, Huang YL, Lin CH*, Chen JW.
Hypertens. Res. 2022; 45(3): 464-473. (IF: 5.525)
Plasma metabolomic profiles associated with hypertension and blood pressure in response to thiazide diuretics.
2022
Huang CC*, Niu DM, Charng MJ*.
J. Atheroscler. Thromb. 2022; 29(5): 639-653. (IF: 4.399)
Genetic Analysis in a Taiwanese Cohort of 750 Index Patients with Clinically Diagnosed Familial Hypercholesterolemia.
2022
Huang CJ, Wang WT, Sung SH, Chen CH, Lip GYH, Cheng HM*, Chiang CE*.
Diabetes Obes. Metab. 2022; 24(12): 2341-2352. (IF: 6.408)
Revisiting 'intensive' blood glucose control: A causal directed acyclic graph-guided systematic review of randomized controlled trials.
2022
Huang HT, Huang JL, Lin PL, Lee YH, Hsu CY, Chung FP, Liao CT, Chiou WR, Lin WY, Liang HW, Chang HY*.
ESC Heart Fail. 2022; doi: 10.1002/ehf2.14107. (IF:3.612)
Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy.
2022
Huang PH, Huang CC*, Lin SJ, Chen JW.
J. Clin. Hypertens. 2022; 24(7): 838-847. (IF: 2.885)
Prediction of atrial fibrillation in patients with hypertension: A comprehensive comparison of office and ambulatory blood pressure measurements.
2022
Huang SH, Liao CF, Chen ZY, Chao TF, Chen SA, Tsao HM*.
Pharmacol. Res. Perspect. 2022; 10(2): e00927. (IF: 2.963)
Distinct atrial remodeling in patients with subclinical atrial fibrillation: Lessons from computed tomographic images.
2022
Huang SY, Lu YY, Lin YK*, Chen YC, Chen YA, Chung CC, Lin WS*, Chen SA, Chen YJ.
Eur. J. Clin. Invest. 2022; 52(4): e13690. (IF: 5.722)
Ceramide modulates electrophysiological characteristics and oxidative stress of pulmonary vein cardiomyocytes.
2022
Huang WC, Lin YH, Wu VC, Chen CH, Siddique S, Chia YC, Tay JC, Sogunuru G, Cheng HM*, Kario K.
J. Clin. Hypertens. 2022; 24(9): 1194-1203. (IF: 2.885)
Who should be screened for primary aldosteronism? A comprehensive review of current evidence.